A multi-center, prospective \& retrospective, observational single-arm study of the clinical outcomes up to one year collected from electronic health records of patients which have undergone standard of care implantation of Impella 5.5, regardless of clinical situation or indication. All patients will be enrolled via an IRB-approved Waiver of Informed Consent and HIPAA Authorization. All patients who were supported retrospectively (prior to site IRB approval) with Impella 5.5 at the investigative site will be entered into the SURPASS registry and specified as the retrospective cohort.
Study Type
OBSERVATIONAL
Enrollment
1,017
Impella 5.5 mechanical circulatory support
Cedars Sinai Medical Center
Los Angeles, California, United States
Advent Health Orlando
Orlando, Florida, United States
Survival Outcome
The rate of patients who survived at Impella 5.5 explant, hospital discharge and follow-up up to 1 year
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tampa General Hospital
Tampa, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
Northwestern University
Evanston, Illinois, United States
Tufts Medical Center
Boston, Massachusetts, United States
MGH
Boston, Massachusetts, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
The Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Cleveland Clinic
Cleveland, Ohio, United States
...and 5 more locations